Status:

COMPLETED

Effect of Targeting Left Ventricular Lead Position on the Rate of Response to Cardiac Resynchronization Therapy.

Lead Sponsor:

University of Calgary

Collaborating Sponsors:

Canadian Institutes of Health Research (CIHR)

Medtronic

Conditions:

Heart Failure, Congestive

Cardiac Pacing, Artificial

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

Identifying \& optimizing strategies to reduce the burden of heart failure is vital. Despite advances in pharmacotherapy, patients with heart failure are at high risk for death \& hospitalization. Car...

Detailed Description

Background. Identifying \& optimizing strategies to reduce the burden of heart failure (HF) is vital. Despite advances in pharmacotherapy, patients with HF are at high risk for death \& hospitalizatio...

Eligibility Criteria

Inclusion

  • LV EF ≤ 0.40 measured within 3 months of enrollment,
  • SAS class 3 or 4 symptoms indicative of moderate to severe functional capacity limitation due to heart failure within 1 month of enrollment.
  • Confirmed dyssynchrony on screening echo (1.1.9), \&
  • On stable doses of ACE inhibitor or angiotensin II blocker \& a beta-blocker for ≥ 2 months unless medically contra-indicated.
  • Controlled heart rate if in permanent AF (resting \<70 \& maximal \<120).

Exclusion

  • Unable or unwilling to provide informed consent,
  • Medical condition other than heart failure likely to cause death \< 1 year,
  • Cardiac transplant planned within 6 months,
  • Known contra-indication to transvenous CRT device implant (e.g., active sepsis, artificial tricuspid valve, known vascular occlusion that will prevent delivery of leads transvenously),
  • Clinically significant myocardial infarction within last 2 months, or
  • Coronary bypass graft surgery ≤ 2 months or coronary angioplasty ≤ 1 month

Key Trial Info

Start Date :

March 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2015

Estimated Enrollment :

96 Patients enrolled

Trial Details

Trial ID

NCT00399594

Start Date

March 1 2011

End Date

November 1 2015

Last Update

November 24 2015

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Foothills Hospital

Calgary, Alberta, Canada, T2N4N1

2

London Health Sciences

London, Ontario, Canada

3

Quebec Heart Institute

Ste-Foy, Quebec, Canada, G1V4G5